(Q36835843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Chronic sildenafil in men with diabetes and erectile dysfunction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Davide Francomano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

6

Giuseppe Barbaro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Roberto Bruzziches

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Cristiana Vitale

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Giuseppe Marazzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Giovanni Spera

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Giuseppe M C Rosano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Metabolism & Toxicology

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

451-464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17539751%20AND%20SRC:MED&resulttype=core&format=json

Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Possible correlation between type 1 diabetes mellitus and female sexual dysfunction: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Metformin improves endothelial function in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Circulating monocyte oxidative activity is increased in patients with type 2 diabetes and erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

The evolving role of testosterone in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Diabetes mellitus is associated with subnormal serum levels of free testosterone in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Phosphodiesterases as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Potency, selectivity, and consequences of nonselectivity of PDE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Expression, distribution and regulation of phosphodiesterase 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Oral drug therapy for erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Phosphodiesterase type 5 inhibitor differentiation based on selectivity, pharmacokinetic, and efficacy profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Phosphodiesterase 5 inhibitors--drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Phosphodiesterase type 5 inhibitors for erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Time course of the interaction between tadalafil and nitrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Sildenafil: A 4-year update in the treatment of 20 million erectile dysfunction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Post-marketing surveillance study of the safety and efficacy of sildenafil prescribed in primary care to erectile dysfunction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Sex and the patient with cardiovascular risk factors: focus on sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

The efficacy and safety of PDE5 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Viagra (sildenafil citrate) and ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Anterior ischemic optic neuropathy associated with viagra

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Tadalafil associated with anterior ischemic optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Sildenafil-associated nonarteritic anterior ischemic optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Endothelial protective effects of preconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Ischemic preconditioning in humans: models, mediators, and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Effects of Sildenafil Citrate (Viagra®) on Hemodynamic Parameters during Exercise Testing and Occurrence of Ventricular Arrhythmias in Patients with Erectile Dysfunction and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: a human in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Cardioprotection with phosphodiesterase-5 inhibition--a novel preconditioning strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Endothelial function in patients with vasculogenic erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

The efficacy of sildenafil citrate (Viagra) in clinical populations: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Endothelial dysfunction: cause of the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451

Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.3.3.451